These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8672465)
21. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor. Han B; Tashjian AH Mol Endocrinol; 1995 Dec; 9(12):1708-19. PubMed ID: 8614407 [TBL] [Abstract][Full Text] [Related]
22. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. Perlman JH; Laakkonen L; Osman R; Gershengorn MC Mol Pharmacol; 1995 Mar; 47(3):480-4. PubMed ID: 7700246 [TBL] [Abstract][Full Text] [Related]
23. Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. Perlman JH; Nussenzveig DR; Osman R; Gershengorn MC J Biol Chem; 1992 Dec; 267(34):24413-7. PubMed ID: 1332958 [TBL] [Abstract][Full Text] [Related]
25. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering. Elling CE; Schwartz TW EMBO J; 1996 Nov; 15(22):6213-9. PubMed ID: 8947044 [TBL] [Abstract][Full Text] [Related]
26. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116 [TBL] [Abstract][Full Text] [Related]
27. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists. Zhorov BS; Folkman EV; Ananthanarayanan VS Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158 [TBL] [Abstract][Full Text] [Related]
28. Understanding the structural and functional differences between mouse thyrotropin-releasing hormone receptors 1 and 2. Deflorian F; Engel S; Colson AO; Raaka BM; Gershengorn MC; Costanzi S Proteins; 2008 May; 71(2):783-94. PubMed ID: 17979196 [TBL] [Abstract][Full Text] [Related]
29. Decreased levels of internalized thyrotropin-releasing hormone receptors after uncoupling from guanine nucleotide-binding protein and phospholipase-C. Nussenzveig DR; Heinflink M; Gershengorn MC Mol Endocrinol; 1993 Sep; 7(9):1105-11. PubMed ID: 8247012 [TBL] [Abstract][Full Text] [Related]
30. Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation. Lin Y; Jian X; Lin Z; Kroog GS; Mantey S; Jensen RT; Battey J; Northup J J Pharmacol Exp Ther; 2000 Sep; 294(3):1053-62. PubMed ID: 10945859 [TBL] [Abstract][Full Text] [Related]
31. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, receptor binding, and activation studies of N(1)-alkyl-L-histidine containing thyrotropin-releasing hormone (TRH) analogues. Kaur N; Monga V; Josan JS; Lu X; Gershengorn MC; Jain R Bioorg Med Chem; 2006 Sep; 14(17):5981-8. PubMed ID: 16735122 [TBL] [Abstract][Full Text] [Related]
33. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific. Falck-Pedersen E; Heinflink M; Alvira M; Nussenzveig DR; Gershengorn MC Mol Pharmacol; 1994 Apr; 45(4):684-9. PubMed ID: 8183247 [TBL] [Abstract][Full Text] [Related]
34. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains. Zhorov BS; Ananthanarayanan VS Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246 [TBL] [Abstract][Full Text] [Related]
35. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore. Axe FU; Bembenek SD; Szalma S J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444 [TBL] [Abstract][Full Text] [Related]
36. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis. Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659 [TBL] [Abstract][Full Text] [Related]
37. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707 [TBL] [Abstract][Full Text] [Related]
38. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor. Neese LL; Wolfe CA; Church FC Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672 [TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation. Rubenstein LA; Zauhar RJ; Lanzara RG J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446 [TBL] [Abstract][Full Text] [Related]
40. Two novel thioamide analogues of TRH with selective activity on CNS. Alexandrová M; Strbák V; Kruszynski M; Zboinska J; Kupryszewski G Gen Physiol Biophys; 1991 Jun; 10(3):287-97. PubMed ID: 1655558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]